Celling Biosciences is advancing the future of medicine through the innovation of point-of-care, autologous regenerative cell therapies.
Our dedicated team of scientists, engineers and physicians are focused on developing point-of-care systems, innovative surgical techniques and technology platforms that create the optimal environment for regenerative cell therapies to promote healing and the regeneration of tissue.
|
|
|
11-50 employees
View all Celling Biosciences employees
|
|
Biotechnology
|
|
4719 South Congress Avenue, Austin, TX 78745, US
|
|
Platelet Rich Plasma, Biotech, Pain Management, Orthopedics, Regenerative Medicine, Stem Cell, Prp, Orthobiologics, Bone Marrow Concentrate
|
Kevin Dunworth is the CEO of Celling Biosciences. To contact Kevin Dunworth email at [email protected]. Or you may call 512 569-1475
The decision makers in Celling Biosciences are C Parker Pruitt, Charles John Verhoeff, Charles Verhoeff, etc. Click to Find Celling Biosciences decision makers emails.
Celling Biosciences specializes in autologous regenerative cell therapies, primarily focusing on Platelet Rich Plasma (PRP) and Bone Marrow Concentrate. These therapies are designed to harness the body's own healing capabilities to treat various conditions, particularly in the fields of orthopedics and pain management.
The point-of-care process at Celling Biosciences involves collecting a patient's own cells, processing them in a sterile environment, and then administering the treatment on-site. This approach minimizes the time between cell collection and therapy application, enhancing the effectiveness of the treatment and ensuring that patients receive immediate care tailored to their individual needs.
Celling Biosciences' regenerative therapies can be used to treat a variety of conditions, including joint pain, tendon injuries, ligament injuries, and other musculoskeletal disorders. These therapies are particularly beneficial for patients seeking alternatives to surgery or those looking to enhance recovery from injuries.
Yes, autologous cell therapies are considered safe because they utilize the patient's own cells, which reduces the risk of rejection and complications associated with donor cells. Celling Biosciences adheres to strict safety protocols and regulatory standards to ensure that all procedures are conducted in a safe and sterile environment.
Celling Biosciences primarily supports the healthcare and biotechnology industries, with a focus on regenerative medicine. Their solutions are utilized by healthcare providers, orthopedic specialists, pain management clinics, and sports medicine practitioners who are looking to incorporate innovative therapies into their treatment offerings.
Healthcare providers interested in partnering with Celling Biosciences can reach out through the contact form on the website or by calling their dedicated support line. The company offers training, resources, and support to help providers integrate point-of-care regenerative therapies into their practice, ensuring they can deliver the best possible care to their patients.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.